StockNews.AI
TMDX
StockNews.AI
207 days

TMDX INVESTIGATION: TransMedics Shares Remain Down Following Report by Scorpion Capital; Investors Encouraged to Contact Block & Leviton to Potentially Recover Losses

1. Block & Leviton investigates TMDX for potential securities law violations. 2. TMDX shares dropped over 11% following a critical investigative report. 3. The report claims fraudulent practices and regulatory scrutiny into TMDX. 4. Customer dissatisfaction reported, with some centers discontinuing TMDX devices. 5. Investors can contact Block & Leviton to potentially recover losses.

5m saved
Insight
Article

FAQ

Why Very Bearish?

The allegations in the report could significantly undermine investor confidence, similar to previous cases where regulatory scrutiny led to price declines.

How important is it?

The investigation and allegations could lead to significant financial consequences for TMDX, directly impacting its stock price.

Why Short Term?

Immediate negative sentiment and potential legal proceedings may impact TMDX in the near term.

Related Companies

TMDX
BOSTON, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating TransMedics Group, Inc. (Nasdaq: TMDX) for potential securities law violations. Investors who have lost money in their TransMedics Group, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/tmdx. What is this all about? Shares of TransMedics Group were down over 11% on January 10, following the release of an investigative report by Scorpion Capital. The report alleges wrongdoing in TransMedics’ business practices, including fraudulent billing schemes, off-label misuse of its devices, and reliance on kickbacks to drive sales. It also highlights ongoing regulatory scrutiny, with reports of investigations by the DOJ, IRS, and state attorneys general into Medicare fraud linked to organ acquisition costs. Additionally, the report makes claims regarding customer dissatisfaction, with prominent transplant centers discontinuing their use of TransMedics devices and citing concerns over their clinical value. Who is eligible? Anyone who purchased TransMedics Group, Inc. common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more. What is Block & Leviton doing? Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money. What should you do next? If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blockleviton.com, or by phone at (888) 256-2510. Whistleblower? If you have non-public information about TransMedics Group, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at shareholders@blockleviton.com or by phone at (888) 256-2510. Why should you contact Block & Leviton? Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website www.blockleviton.com, call (888) 256-2510 or email shareholders@blockleviton.com with any questions. This notice may constitute attorney advertising. CONTACT:BLOCK & LEVITON LLP260 Franklin St., Suite 1860Boston, MA 02110Phone: (888) 256-2510Email: shareholders@blockleviton.com

Related News